Clinical Trials Browser

Interventional × penpulimab × Endocrine × Clear all

NCT06062563 2023-10-02

Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer

Phase NA Unknown

EndocrineHead & Neck

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma

NCT05885399 2023-06-02

The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment

Phase 2 Unknown

Neoplasm Metastasis, Paraganglioma, Extra-Adrenal, Pheochromocytoma